JENA / LONDON (IT BOLTWISE) – The Carl Zeiss Meditec share is stable in the current XETRA session and is up 1.2 percent. Analysts forecast an average price target of EUR 51.61, while the dividend for the current year is estimated at EUR 0.693 per share. Despite the challenges, the company remains an important player in the TecDAX.
Today’s daily deals at Amazon! ˗ˋˏ$ˎˊ˗
The Carl Zeiss Meditec share developed positively in the most recent XETRA session and recorded an increase of 1.2 percent to EUR 43.00. This shows investors’ confidence in the company, despite the volatile market conditions. The previous daily high was reached at EUR 43.34, which indicates stable demand.
At the start of trading the price was EUR 43.26 and 5,367 shares have been traded so far. These figures illustrate investors’ interest in the Carl Zeiss Meditec share, which is proving to be a stable value in the TecDAX. Analysts see an average price target of EUR 51.61, which indicates further growth potential.
Last year, Carl Zeiss Meditec paid a dividend of EUR 0.600, and an increase to EUR 0.693 is expected for the current year. This dividend policy underlines the company’s commitment to providing consistent returns to its shareholders. Experts forecast a profit of EUR 1.72 per share for 2025, which indicates positive business development.
The share reached its 52-week high on March 20, 2025 at EUR 71.65. To reach this level again, the price would have to rise by 66.63 percent. The 52-week low was recorded on September 9, 2025 at EUR 40.52. A further decline of at least 5.77 percent could mark a new low, reflecting the market’s volatility.
Carl Zeiss Meditec’s quarterly financial conference on December 9, 2016 revealed stable earnings per share of EUR 0.38, identical to the same quarter last year. Sales remained constant at EUR 289.77 million, indicating solid business development. This stability is a positive signal for investors looking for long-term growth.
Order an Amazon credit card without an annual fee with a credit limit of 2,000 euros!
Bestseller No. 1 ᵃ⤻ᶻ “KI Gadgets”
Bestseller No. 2 ᵃ⤻ᶻ “KI Gadgets”
Bestseller No. 3 ᵃ⤻ᶻ “KI Gadgets”
Bestseller No. 4 ᵃ⤻ᶻ «KI Gadgets»
Bestseller No. 5 ᵃ⤻ᶻ “KI Gadgets”
Please send any additions and information to the editorial team by email to de-info[at]it-boltwise.de. Since we cannot rule out AI hallucinations, which rarely occur with AI-generated news and content, we ask you to contact us via email and inform us in the event of false statements or misinformation. Please don’t forget to include the article headline in the email: “Carl Zeiss Meditec: Current developments and market perspectives”.